Differences between medical devices and drugs

November 2012 GMTA published the following paper: Differences between medical devices and drugs (PDF)

Patents for Medical Devices and Pharmaceuticals – Summary of Key Differences

November 2012 GMTA published the following paper: Patents for Medical Devices and Pharmaceuticals (PDF)

HTA Position Paper

November 2012 GMTA has published a new Position Paper on HTA. Read the full GMTA Position Paper on HTA (PDF)

HTA Position Paper

The Global Medical Technology Alliance has published a Position Paper on Health Technology Assessment (HTA) (PDF)

COMMENTS ON THE REPORT OF THE WORLD HEALTH ORGANIZATION, “MEDICAL DEVICES: MANAGING THE MISMATCH”

The Global Medical Technology Alliance (GMTA) represents medical technology associations whose members supply nearly 85 percent of the medical devices and diagnostics purchased annually around the world. These members produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments… Continue reading »

The World Health Organization’s Prequalification of Diagnostics Impacts on Diagnostics and Medical Technology to Patients

The Global Medical Technology Alliance (GMTA) member associations represent companies that produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. Our represented companies produce nearly 85 percent of the health care technology purchased and utilized annually around the… Continue reading »

Letter to Dr. Margaret Chan, Director General WHO

December 6, 2010 Dr. Margaret Chan Director General World Health Organization Avenue Appia 20 1211 Geneva 27 Switzerland Dear Director General Chan On behalf of the Global Medical Technology Alliance (GMTA), we are writing to provide you with our promised response to the “Medical Device: Managing the Mismatch” report which was issued at the First… Continue reading »

Product Tendering

This position paper of the Global Medical Technology Alliance (GMTA) is an internal statement of principles intended to offer participating  associations a guideline for consistent non-binding, voluntary application at a national or regional level. As circumstances differ in each market,  national associations should choose whether to use the GMTA principles as an appropriate reflection of… Continue reading »

Global Reimbursement Principles

This position paper of the Global Medical Technology Alliance is an internal statement of principles intended to offer participating associations a guideline for consistent nonbinding, voluntary application at a national or regional level. As circumstances differ in each market, national associations should choose whether to use the GMTA principles as an appropriate reflection of local… Continue reading »

The World Health Organization’s Prequalification of Diagnostics Impacts on Diagnostics and Medical Technology to Patients

The GMTA strongly supports WHO’s mission to increase access to affordable diagnostics of assured quality in underserved regions of the world. We share WHO’s concern for the quality and suitability of diagnostic products intended for use in those regions of the world, and we recognize the need for a product and quality system review of manufacturers not already subject to appropriate regulation.